<DOC>
	<DOC>NCT02890719</DOC>
	<brief_summary>Pilot, single center, open-label study to evaluate the efficacy and tolerability of Grazoprevir and Elbasvir in HCV GT1 and 4 liver transplant recipients.30 liver transplant recipients with hepatitis C recurrence.</brief_summary>
	<brief_title>Pilot Study Evaluate Efficacy of Grazoprevir + Elbasvir for 12 or 16 Weeks in Liver Transplant Recipients.</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<criteria>Age between 18 and 78 yearold. Previous liver transplantation(more than 6 month). Genotype 1 and 4 infection. Hepatitis C recurrence defined by the presence of abnormal liver function test, positive HCVRNA, histological signs of hepatitis C recurrence. Viral load ≥10000UI/mL. Immunosuppression with tacrolimus and/or mycophenolate (Prednisone use is allowed at low dose, ≤10 mg/d). Treatment naïve or treatment experienced (PegRBV or triple therapy). Genotype 2, 3, 5 or 6 infection. Decompensated cirrhosis defined by the presence of actual or previous history of clinical decompensation including ascites, hepatic encephalopathy, variceal bleeding or spontaneous bacterial peritonitis, or a ChildPugh B or C. Hepatocellular carcinoma after liver transplantation. Total bilirubin &gt; 3 mg/dL. Immunosuppression with cyclosporine or an mTOR inhibitor (everolimus or sirolimus). Severe extrahepatic diseases: cardiovascular, respiratory, cerebrovascular and poorly controlled diabetes. Platelets &lt; 75 x 109 cells/L. Neutrophil count &lt; 0.5 x 109 cells/L. Hemoglobin &lt; 9 g/dL. Albumin &lt; 3g/dL. HIV infection. Hepatitis B infection. Active intake of toxic amounts of alcohol or recreational drugs. Females who are pregnant, become to be pregnant or breastfeeding or males whose partners are pregnant, become to be pregnant or breastfeeding. Intake of disallowed medications including(but not limited to): 1. Antibiotics: clarithromycin, erythromycin, telithromycin, nafcillin, rifampin 2. Antifungals: itraconazole, ketoconazole, voriconazole 3. Antihypertensives: nifedipine 4. Anticonvulsants: carbamazepine, phenytoin, phenobarbital 5. Bosentan 6. Modafinil 7. St.Jonh's Wort 8. Immunosuppressants: cyclosporin, everolimus, sirolimus 9. Diabetes agents: glibenclamide, glyburide 10. Lipid lowering agents: gemfibrozil 11. Eltrombopag 12. Lapatinib 13. HIV medications: efavirenz, etravirine, all ritonavir boosted and unboosted HIV protease inhibitors 14. Statins: simvastatin, fluvastatin, rosuvastatin at doses greater than 10 mg/d, atorvastatin at doses greater than 10 mg/d.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>